Clinical Trial Results: Viracept [nelfinavir]

Product Name: Viracept [nelfinavir]
Date of Report: 7/1/2003
Phase: III
Investigation of the gastrointestinal tolerability of a new Roche 625 mg formulation of Viracept (nelfinavir) in subjects with HIV-1 infection.

Product Name: Viracept [nelfinavir]
Date of Report: 10/27/2005
Phase: II
Open, multicenter, randomized, treatment simplification study to evaluate the pharmacological efficacy and safety of a nelfinavir-ritonavir combination one/day (OD) in comparison to nelfinavir twice/day (BID), using the new formulation of nelfinavir 625 mg in HIV-1 patients pretreated with nelfinavir 250 mg.

Product Name: Viracept [nelfinavir]
Date of Report: To be Published
Phase: IV
A Study of the Safety of Viracept (Nelfinavir) in an Expanded Access Program in HIV-1 Positive Women Who are Pregnant or Who Want to Become Pregnant

Product Name: Viracept [nelfinavir]
Date of Report: 5/1/2006
Phase: III
Expanded access program of nelfinavir mesylate new formulation 625 mg in patients with HIV infection.